Stem cell research is no "hotter" than it was four months ago. It's just that irrationalism has gripped the market in the meantime based on the faulty assumption that the Obama Administration is magically going to make every struggling stem cell research company profitable.
I haven't looked at all 32 of the companies listed, but I'm willing to wager that more of these are great short candidates than long candidates right now.
32 Stem Cell Companies to Watch [View article]
I haven't looked at all 32 of the companies listed, but I'm willing to wager that more of these are great short candidates than long candidates right now.